HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Matsuura Selected Research

Cyclin-Dependent Kinase Inhibitor p57

10/2001Expression of p57/Kip2 protein in pancreatic adenocarcinoma.
7/2001Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma.
1/2001Expression of p57/Kip2 protein in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Matsuura Research Topics

Disease

23Carcinoma (Carcinomatosis)
01/2004 - 01/2000
14Neoplasms (Cancer)
02/2011 - 01/2000
10Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2006 - 01/2000
8Hepatocellular Carcinoma (Hepatoma)
05/2009 - 03/2000
8Neoplasm Metastasis (Metastasis)
12/2006 - 06/2000
7Lymphatic Metastasis
03/2001 - 01/2000
5Colorectal Neoplasms (Colorectal Cancer)
03/2007 - 06/2000
5Carcinogenesis
10/2006 - 04/2000
5Adenocarcinoma
10/2001 - 01/2001
4Thyroid Neoplasms (Thyroid Cancer)
08/2003 - 03/2002
3Stomach Neoplasms (Stomach Cancer)
03/2021 - 02/2000
3Colonic Neoplasms (Colon Cancer)
03/2007 - 01/2000
3Papillary Carcinoma
01/2004 - 03/2002
3Adenoma (Adenomas)
01/2004 - 03/2001
3Asthma (Bronchial Asthma)
10/2002 - 02/2001
3Neoplasm Micrometastasis
10/2001 - 06/2000
2Inflammation (Inflammations)
09/2016 - 10/2001
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016 - 04/2016
2Hypertension (High Blood Pressure)
09/2016 - 04/2016
2Fibrosis (Cirrhosis)
09/2016 - 04/2016
2Hypertrophy
04/2016 - 12/2006
2Body Weight (Weight, Body)
04/2016 - 01/2001
2Type 2 Diabetes Mellitus (MODY)
12/2001 - 01/2000
2Bile Duct Neoplasms (Bile Duct Cancer)
10/2001 - 06/2000
2Cognitive Dysfunction
09/2001 - 05/2000
2Breast Neoplasms (Breast Cancer)
05/2001 - 03/2001
2Cholangiocarcinoma
01/2001 - 11/2000
2Heart Failure
06/2000 - 05/2000
2Myocardial Infarction
06/2000 - 05/2000
1Insulin Resistance
04/2016
1Glucose Intolerance
04/2016
1Dyslipidemias (Dyslipidemia)
04/2016
1Postoperative Pain
04/2016
1Esophageal Squamous Cell Carcinoma
02/2011
1Hand-Foot Syndrome
06/2010
1Infections
12/2006
1Adenomatous Polyps
10/2006

Drug/Important Bio-Agent (IBA)

11Biological ProductsIBA
10/2001 - 01/2000
10Proteins (Proteins, Gene)FDA Link
10/2006 - 02/2000
6Epidermal Growth Factor (EGF)IBA
07/2001 - 01/2001
5Fas Ligand Protein (Fas Ligand)IBA
10/2002 - 03/2000
4Insulin (Novolin)FDA Link
05/2006 - 01/2000
4Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
07/2001 - 01/2001
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2001 - 01/2001
4Heparin (Liquaemin)FDA LinkGeneric
07/2001 - 01/2001
4Messenger RNA (mRNA)IBA
07/2001 - 06/2000
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2003 - 04/2000
3AntigensIBA
10/2002 - 01/2001
3Cyclin-Dependent Kinase Inhibitor p57IBA
10/2001 - 01/2001
3Cyclin D1IBA
03/2001 - 01/2000
3Pharmaceutical PreparationsIBA
12/2000 - 05/2000
3gamma-Butyrobetaine DioxygenaseIBA
11/2000 - 05/2000
33-(2,2,2-trimethylhydrazine)propionateIBA
11/2000 - 05/2000
2beta CateninIBA
05/2009 - 01/2001
2DNA (Deoxyribonucleic Acid)IBA
05/2009 - 10/2001
2Phenobarbital (Luminal)FDA Link
01/2006 - 12/2000
2CholesterolIBA
05/2004 - 06/2001
2IntegrinsIBA
01/2003 - 04/2001
2AutoantibodiesIBA
12/2001 - 01/2000
2Immunoglobulin E (IgE)IBA
12/2001 - 01/2001
2AllergensIBA
12/2001 - 01/2001
2ErbB Receptors (EGF Receptor)IBA
07/2001 - 05/2001
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2001 - 06/2000
2Carcinoembryonic AntigenIBA
05/2001 - 06/2000
2Cyclin AIBA
03/2001 - 06/2000
2Polysaccharides (Glycans)IBA
03/2001 - 01/2001
2Phosphates (Orthophosphate)IBA
05/2000 - 01/2000
2EnzymesIBA
04/2000 - 01/2000
1AMP-Activated Protein KinasesIBA
09/2016
1AdiponectinIBA
09/2016
1SaltsIBA
09/2016
1Eicosapentaenoic AcidIBA
09/2016
1Mifepristone (RU 486)FDA Link
04/2016
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
04/2016
1Levobupivacaine (Chirocaine)FDA Link
04/2016
1Ropivacaine (Naropin)FDA LinkGeneric
04/2016
1ATP-Binding Cassette Sub-Family B Member 4IBA
02/2011
1Bevacizumab (Avastin)FDA Link
06/2010
1Bromodeoxyuridine (BrdU)IBA
05/2009
1Interferon-alpha (Interferon Alfa)IBA
05/2009
1InterferonsIBA
05/2009
1Fluorouracil (Carac)FDA LinkGeneric
05/2009
1VimentinIBA
03/2007
1Iodized OilIBA
12/2006
1GelatinIBA
12/2006
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2006
1PPAR deltaIBA
10/2006
1Interleukin-18 (Interleukin 18)IBA
05/2006
1CTLA-4 AntigenIBA
05/2006
1micaIBA
05/2006

Therapy/Procedure

6Therapeutics
05/2009 - 06/2000
2Gastrectomy
03/2021 - 10/2001
2Hepatectomy
12/2006 - 07/2000
2Glycemic Control
12/2001 - 08/2001
2Oral Administration
12/2000 - 05/2000
2Aftercare (After-Treatment)
08/2000 - 05/2000
1Operative Surgical Procedures
03/2021
1Bone Transplantation (Bone Grafting)
04/2016
1Catheters
04/2016
1Chemoprevention
10/2006